The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials

Published:2017-01 Issue: Volume:70 Page:87-98
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Holch Julian Walter,Ricard Ingrid,Stintzing Sebastian^ORCID,Modest Dominik Paul,Heinemann Volker

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features;Missiaglia;Ann Oncol,2014

2. Colorectal cancer: a tale of two sides or a continuum?;Yamauchi;Gut,2012

3. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum;Yamauchi;Gut,2012

4. One colon lumen but two organs;Carethers;Gastroenterology,2011

5. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location;Bufill;Ann Intern Med,1990

Cited by 440 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors;British Journal of Cancer;2024-09-04

2. Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI;ESMO Open;2024-09

3. Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients;Digestive and Liver Disease;2024-08

4. Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer;JCO Clinical Cancer Informatics;2024-07

5. Signaling pathways in colorectal cancer: implications for the target therapies;Molecular Biomedicine;2024-06-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3